PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsMylan
Mylan(MYL)
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AbacavirAbacavir2012-06-182027-2029
AbevmyBevacizumab2021-04-21
AbirateroneAbiraterone2018-10-312027-2038
Abiraterone mylanAbiraterone2021-08-202027-2038
AcamprosateAcamprosate2014-03-11
AccunebAlbuterol2001-04-302024-2041
AcebutololAcebutolol1995-04-24
AcetaminophenAcetaminophen2020-08-072025-2039
AcetazolamideAcetazolamide2012-05-09
AcitretinAcitretin2015-09-10
AcyclovirAcyclovir1998-04-132027-2030
1
2
3
4
5
6
...
47
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bevacizumab
1
2
3
4
5
6
...
16
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use